This site is intended for Healthcare Professionals only.

Britain to trial use of Covid-19 survivors’ blood plasma for treatment

Date:

Share post:

The UK is preparing to collect the blood from Covid-19 survivors to investigate if convalescent plasma transfusions could improve an infected patient’s speed of recovery and chances of survival.

“NHS Blood and Transplant is preparing to collect Covid-19 convalescent plasma from people who have recovered from this illness,” a spokeswoman said. “We envisage that this will be initially used in trials as a possible treatment for Covid-19.”

“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a Covid-19 patient’s speed of recovery and chances of survival,” the blood service said.

“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible.”

People who have recovered from Covid-19 can register with the NHS if they are interested in donating plasma but they should not just turn up at blood donation centres.

(Reuters)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

New Hospital Scheme delays drain millions monthly from ‘scarce’ NHS funds, trust leaders warn

Trust leaders are calling on the next government to commit to constructing 40 new hospitals in England by...

NHS virtual wards set to slash waiting times, prevent 178k admissions in next 2 years

Under the new NHS virtual wards scheme, hospitals to be incentivised for prompt care, with 12-hour A&E target In...

Pharmacist Support: Trainee pharmacists get set to ACTNow for mental health awareness ahead of GPhC assessment

Pharmacist Support's annual mental health awareness campaign offers vital support ahead of GPhC assessment and registration transition Trainee pharmacists...

Two pharmacists sentenced to two years for illegally supplying Class C Drugs

They unlawfully supplied over 55 million doses of Class C drugs diazepam, zolpidem, and zopiclone Southwark Crown Court on...